Compounds > etoposide
Page last updated: 2024-08-23

etoposide and arsenic

etoposide has been researched along with arsenic in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (9.09)18.2507
2000's10 (45.45)29.6817
2010's10 (45.45)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chrétien, P; Huot, J; Lambert, H; Landry, J; Roy, G1
Gallagher, RE; Huang, XJ; Klein, RS; Wiernik, PH1
Goker, E; Karabulut, B; Omay, SB; Sanli, UA; Sezgin, C; Terzioglu, E; Uslu, R1
Bruey, JM; Corcos, L; Garrido, C; Leroy, I; Lizard, G; Miguet, C; Plenchette, S; Rébé, C; Solary, E; Sordet, O1
Au, WY; Chim, CS; Chung, LP; Kwong, YL; Ma, SK1
Li, B; Lou, FD; Wang, YZ; Yao, SQ; Yu, L; Zhu, HL1
Bai, DC; Li, YN; Ma, LF; Peng, X; Wang, P; Wei, HL; Yao, XJ; Zhao, HS1
Mehta, J; Pichardo, D; Rosen, S; Singhal, S1
Karlsson, J; Påhlman, S; Pörn-Ares, I; Øra, I1
Guo, W; Tang, S; Tang, XD; Yang, Y1
Gokhalé, P; Morrison, MJ; Patel, T; Vissers, MC1
Aller, P; Calle, C; de Blas, E; Sánchez, Y1
Cao, F; Gilbert, GE; Heegaard, CW; Hou, J; Rasmussen, JT; Shi, J; Zhang, Y; Zhou, J1
Ayene, IS; Li, J; Prendergast, GC; Ward, KM; Zhang, D1
Christos, PJ; Feldman, EJ; Gergis, U; Mayer, S; Ritchie, EK; Roboz, GJ; Scandura, JM; Wissa, U1
Andersen, ME; Chen, Y; Dong, J; Fu, J; Hou, Y; Pi, J; Qu, W; Tokar, EJ; Waalkes, MP; Wang, A; Woods, CG; Xu, Y; Xue, P; Yarborough, K; Zhan, L; Zhang, H; Zhang, Q1
Beneytout, JL; Bertrand, J; Ghezali, L; Leger, DY; Liagre, B1
Fong, BM; Ho, JC; Lam, SK; Li, YY; Mak, JC; Zheng, CY1
Iland, HJ; Seymour, JF; Wei, A1
Boehme, KA; Handgretinger, R; Kluba, T; Nitsch, J; Riester, R; Schleicher, SB; Traub, F1
Chen, Z; Dai, Y; Gao, F; Guan, G; Liu, L; Ye, Y; Zhao, M; Zhao, P1
Fang, J; Guo, H; Li, Y; Liu, L; Qi, K; Xiong, X; Zhang, C1

Reviews

2 review(s) available for etoposide and arsenic

ArticleYear
Recent developments and future directions in the treatment of multiple myeloma.
    Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:4

    Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow Transplantation; Clinical Trials as Topic; Cysteine Endopeptidases; Diphosphonates; Doxorubicin; Erythropoietin; Etoposide; Forecasting; Humans; Interferons; Multienzyme Complexes; Multiple Myeloma; Organometallic Compounds; Organophosphorus Compounds; Oxides; Peripheral Blood Stem Cell Transplantation; Proteasome Endopeptidase Complex; Thalidomide; Tissue Extracts

2003
Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care.
    Best practice & research. Clinical haematology, 2014, Volume: 27, Issue:1

    Topics: Adult; Age Factors; Aged; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Blood Coagulation Factors; Clinical Trials as Topic; Combined Modality Therapy; Cytarabine; Etoposide; Humans; Hydroxyurea; Idarubicin; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Oxides; Platelet Transfusion; Practice Guidelines as Topic; Remission Induction; Risk Assessment; Thioguanine; Treatment Outcome; Tretinoin

2014

Other Studies

20 other study(ies) available for etoposide and arsenic

ArticleYear
Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein.
    Cancer research, 1991, Oct-01, Volume: 51, Issue:19

    Topics: Animals; Antineoplastic Agents; Arsenic; Arsenites; Blotting, Western; Carmustine; Cell Line; Cell Survival; Colchicine; Cricetinae; Dactinomycin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Fluorouracil; Heat-Shock Proteins; Humans; Hydrogen Peroxide; Pentosyltransferases; Sodium Compounds; Teniposide; Vincristine

1991
Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases.
    Medical oncology (Northwood, London, England), 1999, Volume: 16, Issue:1

    Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase Inhibitors; Caspases; Enzyme Activation; Etoposide; Humans; Leukemia, Myeloid; Oxides; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1999
Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:12

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Butylated Hydroxyanisole; Carcinogens; Cisplatin; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Flow Cytometry; Humans; Male; Ovarian Neoplasms; Oxides; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured

2000
Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis.
    Blood, 2001, Jun-15, Volume: 97, Issue:12

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspases; Cell Differentiation; Cell-Free System; Drug Resistance; Etoposide; Humans; Indazoles; Leukemia; Mitochondria; Oxides; Proto-Oncogene Proteins c-bcl-2; Tetradecanoylphorbol Acetate; U937 Cells

2001
Two cases of therapy-related acute promyelocytic leukemia (t-APL) after mantle cell lymphoma and gestational trophoblastic disease.
    Annals of hematology, 2002, Volume: 81, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Arsenic Trioxide; Arsenicals; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Leukemia, Promyelocytic, Acute; Lymphoma, Mantle-Cell; Male; Neoplasms, Second Primary; Oxides; Pregnancy; Tretinoin

2002
[The expression of Fas, FasL and Bcl-2 on RMA cells during the process of apoptosis induced by chemotherapeutic drugs].
    Zhongguo shi yan xue ye xue za zhi, 2002, Volume: 10, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Dexamethasone; Etoposide; Fas Ligand Protein; fas Receptor; Gene Expression; Membrane Glycoproteins; Mice; Oxides; Proto-Oncogene Proteins c-bcl-2; Tretinoin; Tumor Cells, Cultured

2002
[Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2003, Volume: 24, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Humans; K562 Cells; Oxides

2003
Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, May-01, Volume: 10, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Blotting, Western; Calpain; Carboplatin; Caspase 3; Caspases; Cell Line, Tumor; Cytochromes c; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Mutation; Neuroblastoma; Oxides; Proto-Oncogene Proteins c-bcl-2; Time Factors; Tumor Suppressor Protein p53; Vincristine

2004
[Preliminary report of combination chemotherapy including Arsenic trioxide for stage III osteosarcoma and Ewing sarcoma].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2006, Jun-15, Volume: 44, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Neoplasms; Child; Etoposide; Female; Follow-Up Studies; Humans; Male; Osteosarcoma; Oxides; Paclitaxel; Sarcoma, Ewing; Treatment Outcome

2006
The effect of intracellular ascorbate on the susceptibility of HL60 and Jurkat cells to chemotherapy agents.
    Apoptosis : an international journal on programmed cell death, 2006, Volume: 11, Issue:10

    Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Caspases; Cell Count; Dehydroascorbic Acid; Drug Resistance, Neoplasm; Etoposide; HL-60 Cells; Humans; Jurkat Cells; Melphalan; Oxides

2006
Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases.
    Chemico-biological interactions, 2009, Nov-10, Volume: 182, Issue:1

    Topics: Adamantane; Antineoplastic Agents; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Catechin; Cell Cycle; Drug Synergism; Enzyme Activation; Estradiol; Etoposide; Genistein; HL-60 Cells; Humans; Hydroquinones; Immunoblotting; Microscopy, Fluorescence; Mitogen-Activated Protein Kinases; Oxides; Protein Kinase Inhibitors; Reactive Oxygen Species; RNA, Small Interfering; U937 Cells

2009
Phosphatidylserine exposure and procoagulant activity in acute promyelocytic leukemia.
    Journal of thrombosis and haemostasis : JTH, 2010, Volume: 8, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blood Coagulation; Blood Coagulation Tests; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Survival; Daunorubicin; Etoposide; Factor Xa; Female; Flow Cytometry; Humans; Leukemia, Promyelocytic, Acute; Male; Membrane Glycoproteins; Microscopy, Confocal; Milk Proteins; Oxides; Phosphatidylserines; Thrombin; Thromboplastin; Tretinoin; Young Adult

2010
Hydroxyethyl disulfide as an efficient metabolic assay for cell viability in vitro.
    Toxicology in vitro : an international journal published in association with BIBRA, 2012, Volume: 26, Issue:4

    Topics: Acetaminophen; Arsenicals; Arsenites; Biological Assay; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Disulfides; Ethanol; Etoposide; Humans; Hydrogen Peroxide; Hypoxia; Radiation, Ionizing; Toxicity Tests

2012
Are low-intensity induction strategies better for older patients with acute myeloid leukemia?
    Leukemia research, 2012, Volume: 36, Issue:4

    Topics: Aged; Aged, 80 and over; Aminoglycosides; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cytarabine; Daunorubicin; Etoposide; Female; Gemtuzumab; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Oxides; Quinolones; Remission Induction; Retrospective Studies; Treatment Outcome

2012
Regulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells.
    Free radical biology & medicine, 2012, Aug-15, Volume: 53, Issue:4

    Topics: Antineoplastic Agents; Antioxidant Response Elements; Arsenic Trioxide; Arsenicals; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation; Gene Knockdown Techniques; Glutamate-Cysteine Ligase; Heme Oxygenase-1; Humans; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; Models, Biological; NAD(P)H Dehydrogenase (Quinone); Neoplastic Stem Cells; NF-E2-Related Factor 2; Oxides; PPAR gamma; Proto-Oncogene Mas; RNA Interference; Rosiglitazone; Thiazolidinediones

2012
Cyclooxygenase-2 positively regulates Akt signalling and enhances survival of erythroleukemia cells exposed to anticancer agents.
    Apoptosis : an international journal on programmed cell death, 2013, Volume: 18, Issue:7

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Casein Kinase II; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Erythroblastic, Acute; Oxides; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; RNA, Small Interfering; Signal Transduction; Staurosporine

2013
Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2013, Volume: 82, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Cisplatin; Disease Models, Animal; DNA Damage; Drug Synergism; Etoposide; Female; Glutathione; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Oxides; Reactive Oxygen Species; Small Cell Lung Carcinoma; Xenograft Model Antitumor Assays

2013
Arsenic trioxide potentiates the effectiveness of etoposide in Ewing sarcomas.
    International journal of oncology, 2016, Volume: 49, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Bone Neoplasms; Drug Synergism; Etoposide; Flow Cytometry; Humans; Oxides; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma, Ewing; Tumor Cells, Cultured

2016
[Influence of HMGB1/MAPK/m-TOR signaling pathway on cell autophagy and chemotherapy resistance in K562 cells].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2016, Oct-28, Volume: 41, Issue:10

    Topics: AMP-Activated Protein Kinases; Arsenic Trioxide; Arsenicals; Autophagy; Cytarabine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; HMGB1 Protein; Humans; K562 Cells; Microtubule-Associated Proteins; Oxides; RNA, Small Interfering; Signal Transduction; TOR Serine-Threonine Kinases; Vincristine

2016
Low dose of arsenic trioxide inhibits multidrug resistant-related P-glycoprotein expression in human neuroblastoma cell line.
    International journal of oncology, 2016, Volume: 49, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; G2 Phase Cell Cycle Checkpoints; Humans; Neuroblastoma; Oxides

2016